E1 | Upper left, eyelid |
E2 | Lower left, eyelid |
E3 | Upper right, eyelid |
E4 | Lower right, eyelid |
EA | Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy |
EB | Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy |
EC | Erythropoetic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy |
ED | Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle |
EE | Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle |
EJ | Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab |
EM | Emergency reserve supply (for esrd benefit only) |
EP | Service provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program |
ET | Emergency services |
EX | Expatriate beneficiary |
EY | No physician or other licensed health care provider order for this item or service |
General
Content
Integrations